Psychiatry & Neurology, Neuromuscular Medicine · Fresno, CA
NPI
1811912348
Since 2006
Specialty
Psychiatry & Neurology, Neuromuscular Medicine
Code 2084N0008X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2335 E Kashian Ln, Suite 301
Fresno, CA, 93701
Phone (559) 264-9100
Groups this clinician bills Medicare through
Medicare paid, 2024
$46K
541 services
Medicare patients, 2024
168
Average age 64
Drug cost, 2024
$8.0M
825 prescriptions
Company payments, 2025
$70K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey Rosenfeld was code 99215 (office e&m - established), 184 times for 103 patients. In total Jeffrey Rosenfeld billed 541 services in 27 codes, and Medicare paid $46K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-06-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 184 | 103 | $132.37 | $24K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 155 | 85 | $12.66 | $1,962 |
| 99214 Office E&M - Established | Office | 43 | 35 | $99.03 | $4,258 |
| 95885 Electrical Nerve Conductivity | Office | 29 | 21 | $51.34 | $1,489 |
| 99205 Office E&M - New | Office | 18 | 18 | $159.90 | $2,878 |
By year: 2022 $50K for 443 services; 2023 $46K for 421 services; 2024 $46K for 541 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey Rosenfeld prescribed most often to Medicare patients was Radicava Ors (Edaravone), with 166 prescriptions and refills. In total Jeffrey Rosenfeld wrote 825 Medicare prescriptions that cost $8.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Radicava Ors Edaravone | 166 | 166 | 23 | $2.3M |
| Riluzole Generic | 81 | 169 | 25 | $23K |
| Evrysdi Risdiplam | 73 | 73 | Under 11 | $1.9M |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 47 | 47 | Under 11 | $590K |
| Baclofen Generic | 38 | 66 | 13 | $1,388 |
| Pyridostigmine Bromide Generic | 36 | 56 | Under 11 | $1,994 |
| Gabapentin Generic | 31 | 47 | Under 11 | $596 |
| Tizanidine Hcl Generic | 30 | 52 | Under 11 | $767 |
| Nuedexta Dextromethorphan Hbr/Quinidine | 27 | 41 | Under 11 | $62K |
| Vyvgart Efgartigimod Alfa-Fcab | 23 | 27 | Under 11 | $1.7M |
| Sodium Chloride 0.9 % Sodium Chloride | 20 | 20 | Under 11 | $170 |
| Dantrolene Sodium Generic | 18 | 34 | Under 11 | $1,480 |
| Pregabalin Generic | 18 | 18 | Under 11 | $133 |
| Prednisone Generic | 17 | 24 | Under 11 | $139 |
| Pyridostigmine Bromide Er Pyridostigmine Bromide | 15 | 19 | Under 11 | $4,133 |
Brand drugs: 409 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey Rosenfeld $70K ($70K in general payments such as food, travel and fees) from 9 companies. The largest payer was Argenx US, Inc. with $50K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.